Newly launched genomics company Helix has secured investment from founding partners including Illumina, and additional cash from strategic partner Mayo Clinic.
US-based genomics technology developer Helix was launched today by biotechnology company Illumina and private equity firms Warburg Pincus and Sutter Hill Ventures with more than $100m of funding.
Medical practice Mayo Clinic has also contributed funds as part of a partnership agreement with Helix. The partnership, made through Mayo Clinic’s Center for Individualized Medicine, will focus on consumer education and health-related questions.
Laboratory services provider LabCorp will also work with Helix to set up a service that will offer consumers…
